The role of infections in the emergence of non-communicable diseases (NCDs): Compelling needs for novel strategies in the developing world

Journal of Infection and Public Health

Volumn 2, Issue 1, 2009, Pages 14-29

  Ogoina, Dimie ^a   Onyemelukwe, Geofrey C ^b  

^a AHMADU BELLO UNIVERSITY   (Nigeria)

^b Immunology Unit   (Nigeria)

Author keywords

Cancer; Chronic disease; Developing countries; Infections; Non communicable diseases

Indexed keywords

CARCINOGEN;

ANTIMICROBIAL THERAPY; ASTHMA; AUTOIMMUNITY; BACTERIAL INFECTION; BLINDNESS; CALCIFICATION; CANCER INHIBITION; CELL TRANSFORMATION; CHRONIC INFLAMMATION; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY DISEASE; DEVELOPING COUNTRY; DIABETES MELLITUS; ENDOGENOUS RETROVIRUS; ENVIRONMENTAL FACTOR; ERYTHROCYTE; GENE ACTIVATION; GENETIC DISORDER; HEART DISEASE; HOST; HUMAN; HYPERSENSITIVITY; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; INFECTION CONTROL; INTRAUTERINE INFECTION; KIDNEY DISEASE; MALARIA; MALNUTRITION; MENTAL DISEASE; METAPLASIA; NEOPLASM; OBESITY; ONCOGENE; OSTEOPOROSIS; PEPTIC ULCER; PHYSICAL DISABILITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SICKLE CELL ANEMIA; SPLENOMEGALY; STROKE; SYSTEMIC DISEASE; VACCINATION; VIRUS INFECTION;

AUTOIMMUNITY; CHRONIC DISEASE; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; DEVELOPING COUNTRIES; HUMANS; HYPERSENSITIVITY; INFLAMMATION; NEOPLASMS; RISK FACTORS;

EID: 62349124408     PISSN: 18760341     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jiph.2009.02.001     Document Type: Review

References (117)

1. Facts on chronic disease: WHO Publication 2005. Retrieved August 2008. Available at www.who.int.
2. Chronic diseases, facing the facts. WHO publication 2008. http://www.who.int/clip/chronic-disease-report/en/.
3. Non-communicable diseases. Publication of Disease Control Priorities Project 2006. The World Bank. Available at www.worldbank.org.
4. Surveillance of non-communicable diseases risk factors. WHO publication retrieved January 2008. www.who.int/mediacentre/factsheets/fs273/en/.
5. Suerbaum S., and Michetti P. Helicobacter pylori infection. N Engl J Med 347 October 10 (15) (2002) 1175-1186
6. Barker D.J. The development origin of adult disease. Am Coll Nutr 23 6 (2004) 588-595
7. Scott J. Homocysteine and cardiovascular disease. Q J Med 89 (1996) 561-563
8. Top 10 causes of Death. WHO Fact Sheet. March 2007. http://www.who.int/medicentre/factsheets/ts310.pdf.
9. Barreto M.L., Teixeira M.G., and Carmo H.E. Infectious disease epidemiology. J Epidemiol Comm Health 60 (2006) 192-195
10. Daar A.S., Singer P.A., Persad D.L., Pramming S.K., Matthews D.R., Beaglehole R., et al. Grand challenges in chronic non-communicable diseases. Nature November (450) (2007) 494-496
11. Meador RJ. Acute rheumatic fever. E-medicine article updated October 22, 2007. Available at www.e-medicine.com.
12. Bahn B.J., and Appelt D.M. Role of infection in Alzheimer's disease. J Am Osteopath Assoc 101 December (12 Suppl.) (2001) 1-6
13. Dienstag J.L., and Isselbacher K.J. Tumours of the liver and biliary tract. In: Braunwald F., et al. (Ed). Harrison's principles of internal medicine. 15th ed. vol. 91, no. 1 (2001), McGraw Hill (Pub.) p. 588-589
14. Fakunle Y.M., Ajdukiewic A.B., Greenwood B., and Edington G.M. Primary liver cell carcinoma (PLCC) in the northern Guinea savannah of Nigeria. Trans Roy Soc Trop Med Hyg 71 4 (1977)
15. Bouman A., Heineman M.J., and Faas M.M. Sex hormones and the immune response in humans. Hum Rep Update 11 4 (2005) 411-423
16. Adrain Hill. The immunogentics of human infectious diseases. Annu Rev Immunol 16 (1998) 593-617
17. Bach Jean Francois. The effect of infectious in susceptibility to autoimmune and allergic diseases. N Engl J Med 347 September (12) (2002) 911-920
18. Richard R. Human papillomaviruses (HPV). In: Braunwald F., et al. (Ed). Harrison's principles of internal medicine. 15th ed. vol. 1, no. 188 (2001), McGraw Hill (Pub.) p. 1118-1120
19. Brady H., O'meara Y., and Brenner B. The major glomerulopathies. In: Braunwald F., et al. (Ed). Harrison's principle of internal medicine. 15th ed. vol. 1, no. 274 (2001), McGraw Hill (Pub.) p. 158
20. Mohammed I. The role of immune complexes in human malaria and some of its complications. J Infect 4 (1982) 97-104
21. Barsoum R. Malarial Nephropathies. Nephrol Dial Transplant 13 (1998) 1588-1597
22. John Gever: Smoking conspires with viruses to advance COPD. MedpageToday, July 24, 2008. www.medpagetoday.com/pulmonary/smokingCOPD/ts/10249.
23. Strachan D.P. Hay fever, hygiene and household size. Br Med J 299 (1989) 1259-1260
24. Smith RS, Bloomfield S. The hygiene hypothesis and implications for home hygiene. Report of the international scientific forum on Home Hygiene, 2004.
25. Greenwood B.M., and Voller A. Suppression of autoimmune disease in New Zealand Mice associated with infection with Malaria I & II. Clin. Exp. Immunol. 8 (1970) 793 and 805
26. Epstein F. Atherosclerosis-an inflammatory disease. N Engl J Med 340 2 (1999) 115-126
27. Eder W., Ege M., and Von-Mutius E. The asthma epidemic. N Engl J Med 355 November (21) (2006) 2226-2235
28. Microbial Triggers of Chronic illness. Publication of American Academy of Microbiology 2005. www.asm.org.
29. Strange Bed fellows; Infection and Chronic disease. Conference report. Canadian Public Health Association 2001. www.cpha.com.
30. Connor S.M., Taylor C.E., and Hughes S. Emerging infectious determinants of chronic diseases. Emerg Infect Dis 12 July (7) (2006) 1051-1057
31. Pincus S. Potential role of infectious in chronic inflammatory diseases vol. 71, no. 1 (2006), ASM Press p. 529-535
32. Scarisbrick A., and Rodriguez M. Hit-Hit and Hit run. Viruses in the playing field of multiple sclerosis. Curr Neuro Neurosci Rep 3 June (3) (2003) 265-271
33. Noseworthy J., Lucchiretti C., Rodriguez M., and Weinsheinker B. Multiple Sclerosis. N Engl J Med September 28 (2000) 938-952
34. Sanjay Sethi. Bacterial Infections and the pathogenesis of COPD. Chest 117 (2000) 2865-2913
35. Hemalatha V., Srikanth P., and Mallika M. Superantigens-concepts, clinical disease and therapy. Int J Med Microbiol 22 4 (2004) 204-211
36. Platts-Mill T., Male D., Hay F., Britton W., and Westwood O. Hypersensitivity reactions. In: Ivam R., Brostoff J., and Male D. (Eds). Immunology. 6th ed. (2001), Mosby (Pub.) p. 323-382
37. Lori A., and Inman R.D. Molecular mimicry and autoimmunity. N Engl J Med December (1999) 2068-2074
38. Autoimmunity and autoimmune disease. In: Ivam R., Brostoff J., and Male D. (Eds). Immunology. 6th ed. (2001), Mosby (Pub.) p. 401-415
39. Hypersensitivity. In Wikipedia Free encyclopedia updated 31 July 2008. Available at www.wikipedia.com.
40. Carty S.M., Snowden N., and Silman A.J. Should infection still be considered as the most likely triggering factor for rheumatoid arthritis?. Ann Rheum Dis 63 Suppl. 11 (2004) i46-ii49
41. Cancer. WHO Fact Sheet. 2006, Feb. Available at www.who.int.
42. Cancer. In Wikipedia free encyclopedia. 2008 January. Available at www.wikipedia.com.
43. Kim C., Koke K., Saito L., Miyamura T., and Jay G. HBX gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351 May 23 (1991) 317-320
44. Brechot C. Pathogenesis of hepatitis B virus related hepatocellular carcinoma; old and new paradigms. Gastroenterology 127 5 (2003) 556-561
45. Gravitt P. HPV: the ultimate cancer initiator. HPV Today Monogr 3 September (2003) 1-4
46. Yasunagu J., and Matsuoka M. Human T-cell leukemia virus, type 1 induces adult T cell leukemia: from clinical aspects to molecular mechanism. Cancer Control 14 April (2) (2007) 133-140
47. Cohen J.I. Epstein-Barr virus infection. N Engl J Med 343 August 17 (7) (2000) 481-492
48. Ming L., Thorgeirsson S.S., Gail M.H., Lu P., Harris C.C., Wang N., et al. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology 36 November (5) (2002) 1046
49. Ndububa D.A., Yakicier C.M., Ojo O.S., Adeodu O.O., Rotimi O., Ogunbiyi O., et al. P53 Codon 249 mutation in hepatocellular carcinoma from Nigeria. Afr J Med Med Sci 30 March-June (1-2) (2001) 125-127
50. 2 in primary liver cell carcinoma. Toxico Lett 10 February (2-3) (1982) 309-312
51. Onyemelukwe G.C., Nirodi C., and West C.E. Aflatoxin B in hepatocellular carcinoma. Trop Geogr Med 32 September (3) (1980) 237-240
52. Khurana S., Dubey M.L., and Malla N. Association of parasitic infections and cancers. Indian J Med Microbiol 23 2 (2005) 74-79
53. Rezaee J.A., Cunningham C., Davison A., and Blackbourn D.J. Kaposi's sarcoma associated herpes virus immune modulation: an overview. J Gen Virol 87 (2006) 1781-1804
54. Lederman M. Immunopathogenesis of HIV; In HIV In-site Knowledge base. January 2006. Available at www.hivinsite.com.
55. Beverley P. Tumour immunology. In: Roit I., Brostof H., and Male D. (Eds). Immunology. 6th ed. (2001), Mosby (Pub.) p. 289-300
56. Schouten JT. AIDS-Related Cancer; An update; In The Body, Retrieved August 2008, http://www/thebody.com/content/cert,4400.html.
57. Whittle H.C., Brown J., Marsh K., Blackman M., Jobe O., and Shenton F. The effects of plasmodium Falciparum on immune control of B lymphocytes in Gambian children. Clin Exp Immunol 80 May (2) (1990) 213-218
58. Lubega J. T-helper 1 versus T-helper 2 lymphocyte immunodysregulation is the central factor in genesis of Burkitt's lymphoma; hypothesis. Infect Agents Cancer 2 10 (2007) 2-10
59. Forrester T. Historic and early life origins of hypertension in Africans. J Nutr 134 (2004) 211-216
60. Malaria in pregnancy. Roll back malaria, WHO Retrieved August 2008. http://www.int/CMC-upload,10/000/015/369/RBMinfosheet_4.htm.
61. Dogra SV. Intrauterine growth retardation. Update. Dec. 28, 2006. e-medicine, available at www.emedicine.com.
62. Intrauterine growth retardation in newborn children. WHO publication. http://www/who.int/ceh/indication/ugrnewborn.pdf. Retrieved August 2008.
63. Brown A.S. Prenatal Infections as a risk factor for schizophrenia. Schizophrenia Bull 32 2 (2006) 200-202
64. Falase A.O., Sekoni G.A., and Adenle A.D. Dilated cardiomyopathy in young Africans; a sequel to infections. Afr J Med Med Sci 11 (1982) 1-5
65. Falase A.O. Infections dilated cardiomyopathy in Nigeria. Heart Vessels Suppl 1 (1985) 40-44
66. Cook P.J., and Lip G.Y. Infectious agents and atherosclerotic vascular disease. Q J Med 89 (1996) 727-735
67. Cook P.J., Lip G.Y., Davies P., Beevers D.G., Wise R., and Honeybourne D. Chlamydia pneumonia antibodies in severe essential hypertension. Hypertension 31 (1998) 589-594
68. Wimmer M.L., Sandmann-Strupp R., Saikku P., and Haberl R.L. Association of Chlamydia Infection with Cardiovascular disease. Stroke 27 December (12) (1996) 2207-2210
69. Falase A.O. Peripartum heart disease. Heart Vessels Suppl 1 (1985) 232-235
70. Cenac C., Djibo A., Sueur J.M., Chaigneau C., and Orfila J. Chlamydia infection and Peripartum Cardiomyopathy. Nigerian Med Trops (Mars) 60 2 (2000) 137-140
71. Bhakta P., Biswas B., and Barnerjee B. Peripartum Cardiomyopathy. Yonsei Med J 48 5 (2007) 731-747
72. Ford l., Abdullahi A., Anjorin F., Danbauchi S., Isa M., Mauda G., et al. The outcome of peripartum cardiac failure in zaria. Nigeria Q J Med 91 (1998) 93-103
73. Wynne J., and Braunwald E. The Cardiomyopathies and Myocarditis. In: Braunwald F., et al. (Ed). Harisson's principles of internal medicine. 15th ed. vol. 238 (2001), McGraw Hill (Pub.) p. 1359-1365
74. Jaiyesimi F. Controversies and advances in Endomyocardial fibrosis-a review. Afr J Med Med Sci 11 (1982) 37-46
75. Andy J.J. Aetiology of Endomyocardial fibrosis (EMF). West Afr J Med 20 July-September (3) (2001) 199-207
76. Andy J.J., Ogunowo P.O., Akpan N.A., Odigwe C.O., Ekanem I.A., and Esin R.A. Helminth associated hypereosinophilia and tropical endomyocardial fibrosis (EMF) in Nigeria. Acta Tropica 69 May (2) (1998) 127-140
77. Marshall B.J., and Warren J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1 (1984) 1311
78. Gasbarrini A., Franceschi F., Armuzzi A., Ojetti V., Candelli M., Torre E., et al. Extradigestive manifestations of Helicobacter pylori gastric infection. Gut 45 (1999) 9-12
79. Paparello S., and Hoffman S. Hyper-reactive malarial splenomegaly I & II. Postgrad Doct Afr 15 2-3 (1993) 20-24 48-51
80. Bryceson A., Fakunle Y.M., Fleming A.F., Crane G., Hutt M.S., de Cock K.M., et al. Malaria and splenomegaly. Trans Soc Trop Med Hyg 77 (1983) 879-883
81. Ramakrishna B.S., Venkataraman S., and Mukhopadhy G.A. Tropical malabsorption. Postgrad Med J 82 (2006) 779-787
82. Fenollar F., Puechal X., and Raoult D. Whipple's disease. N Engl J Med 356 (2007) 55-66
83. Water related diseases. WHO 2008. Available at www.who.int.
84. Beisel W.R. Infection induced malnutrition; from cholera to cytokines. Am J Clin Nutr 62 (1995) 813-819
85. Dhurandhar N. Infectoberity: obesity of infectious origin. J Nutr 131 (2001) 2794-2797
86. Prusiner S.B. Novel Proteinaceous infectious particles cause Scrapie. Science 216 (1982) 136-144
87. Johnson R.T., and Gibbs C.J. Creutzfeldt-Jakob disease and related transmissible Spongiform Encephalopathies. N Engl J Med 339 December 31 (27) (1998) 1994-2004
88. The Emerging Role of Infection in Alzheimer, Disease IOS Press 2008, May 25. Science Daily. Retrieved August 9, 2008.
89. Vitiello B, Vitkovic L. The links between infections and Psychiatric Diseases. Medscape Psychiatry & Mental Health e-Journal, 1997, 2 (2) Retrieved August 2008.
90. Gessaini A., Francis H., Sonan T., Giordano C., Akani F., Piquemal M., et al. HTLV-1 and Tropical spastic paraparesis in Africa. Lancet 2 September 20 (8508) (1986) 698
91. Cabre P., Smadja D., Cabie A., and Newton C.J. HTLV-1 and HIV infection of the Central Nervous System in tropical areas. J Neurol Neurosurg Psychiatry 68 (2000) 550-557
92. Ali G., Rashid S., Kamli M.A., Shah P.A., and Allaqaband G.Q. Spectrum of neuropsychiatric complications in 791 cases of typhoid fever. Trop Med Int health 2 4 (1997) 314-318
93. Danbauchi S.S. Malaria presenting with self limiting cerebellar syndrome. Nigerian J Med 4 1 (1995) 18-20
94. Garg R.K., Kerak B., and Misra S. Neurological manifestation of malaria: an update. Neurol India 47 (1999) 85-91
95. Poliomyelitis. WHO Fact sheet Update January 2008. Available at www.who.int.
96. Wild poliovirus weekly update; publication of Global polio eradication initiative. 2008, Aug 6. http://www.polioeradication.org/casecount.asp.
97. Leprosy. WHO fact sheet October 2005. Retrieved August 2008. Available at www.who.int.
98. Kibukamusoke J.W. (ed.) Tropical Nephropathy Citforge Pty Ltd, G.P.O. Box 1291, Canberra City, ACT 2601, Australia, 1984.
99. Akinkugbe O.O. Tropical nephropathy: an overview. Afr J Med Med Sci 21 October (1) (1992) 3-7
100. Gilles H.N., and Hendrichse R.G. Nephrosis in Nigerian Children Role of Malaria and effect of antimalarial treatment. Br Med J 2 (1963) 27
101. Kibukamusoke J.W., Hunt M.R., and Wilkes N.E. The Nephrotic syndrome in Ugandan and its association with Quartan Malaraie. Q J Med 36 (1967) 393
102. Aikhonbare H.A., and Abdulrahman M.B. Acute glomerulonephritis in Zaria, Nigeria. Nig. J. Pediatrics 11 2 (1984) 59-62
103. Abdurrahman M.B. The role of infectious agents in the aetiology and pathogenesis of childhood nephritic syndrome in Africa. J Infect 8 March (2) (1984) 100-109
104. Gencay J.B., Ridiger J., Tamm M., Soler M., Perruchoud A., and Roth M. Increased frequency of Chlamydia pneumonia antibodies in patients with asthma. Am J Respir Crit Care Med 163 (2001) 1097-1100
105. Wjst M., and Boakye D. Asthma in Africa. PLOS Med 4 February (2) (2007) e72 0203-0205
106. Onyemelukwe G.C., Shakib F., Saeed T.K., Salloum Z.A., Lawande R.V., and Obineche E. RAST-specific IgE in Nigerian asthmatic patients. Ann Allergy 56 February (2) (1986) 167-170
107. Casell G.H. Infectious causes of chronic inflammatory disease and cancer. Emerg Infect Dis 4 July-September (3) (1998)
108. Malaria. WHO fact sheet 2007, May, Retrieved August 2008. Available at www.who.int.
109. Nagel R.L., and Roth E.F. Malaria and red cell genetic defects. Blood 74 (1989) 1213-1221
110. Malaria and the sickle cell Hemoglobin Gene 2002. April. Available at www.sickle.bioh.harvard.edu/malariasickle.html.
111. Adaptation by Natural selection; Sickle cell Hemoglobin and Malaria. http://www.as.ua.edu/ant/bindos/ant475/sicklecell/sicklecell.pdf. 2004.
112. Usanga E.A., and Luzzatto L. Adaptation of plasmodium falciparum to glucose-6-phosphate dehydrogenase deficient host red cells by production of parasite encoded enzyme. Nature 313 (1985) 793-795
113. Kajander E.O., and Ciftcioglu N. Nanobacteria: an alternative mechanism for pathogenic intra- and extra cellular calcification and stone formation. Proc Natl Acad Sci USA 95 July (1998) 874-889
114. Urbano P., and Urbano F. Nanobacteria: facts or fancies. PLOS Pathogens 3 5 (2007) e55 0567-0570
115. Nelson P.N., Carnegie P.R., Martin J., Ejtehadi D., Hooley P., Roden D., et al. Demystified-Human Endogenous Retroviruses. Mol Pathol 56 February (1) (2003) 11-18
116. WHO fact sheet. Immunization against diseases of public health importance. March 2005. Available at www.who.int.
117. Ekwempu C.C. Infection Theory of Eclampsia Re-evaluated. Int J Gynaecol Obstect 18 4 (1980) 300-302